SEC Form 4 · accession 0001209191-18-045833
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ginger L Graham
Director
Period of report
Aug 6, 2018
Accepted (ET)
Aug 8, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 6, 2018 | M | 16,500 | $17.33 | A | 26,756 | I | Held by the GInger L. Graham Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $17.33 | Aug 6, 2018 | M | 16,500 | D | — | Dec 4, 2018 | Common Stock | 16,500 | 0 | D |
Explanation of responses
- F1The option became exercisable as to 25% of the shares on December 4, 2009, and became exercisable as to 1/48th of the shares each full month thereafter.